Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
docetaxel (taxotere) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Lung Neoplasms (Phase 4)
Trials (1 total)
Trial APIs (2 total)